Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy
Publication
, Conference
Krasuski, R; Whitney, E; Kolasa, M; Zagol, B; Personius, B; Michalek, J; Brown, B; Gotto, A
Published in: EUROPEAN HEART JOURNAL
2004
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
2004
Volume
25
Start / End Page
50 / 50
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Krasuski, R., Whitney, E., Kolasa, M., Zagol, B., Personius, B., Michalek, J., … Gotto, A. (2004). Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy. In EUROPEAN HEART JOURNAL (Vol. 25, pp. 50–50).
Krasuski, R., E. Whitney, M. Kolasa, B. Zagol, B. Personius, J. Michalek, B. Brown, and A. Gotto. “Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy.” In EUROPEAN HEART JOURNAL, 25:50–50, 2004.
Krasuski R, Whitney E, Kolasa M, Zagol B, Personius B, Michalek J, et al. Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy. In: EUROPEAN HEART JOURNAL. 2004. p. 50–50.
Krasuski, R., et al. “Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy.” EUROPEAN HEART JOURNAL, vol. 25, 2004, pp. 50–50.
Krasuski R, Whitney E, Kolasa M, Zagol B, Personius B, Michalek J, Brown B, Gotto A. Elevation of high density lipoprotein cholesterol and not anti-inflammatory effect accounts for the reduction in clinical events with combination gemfibrozil, niacin and cholestyramine therapy. EUROPEAN HEART JOURNAL. 2004. p. 50–50.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
2004
Volume
25
Start / End Page
50 / 50
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology